T.M., M.B.). The online-only Data Supplement is available with this article at http://circres.ahajournals.org/lookup/suppl/Rationale: Genetic tracing experiments and cell lineage analyses are complementary approaches that give information about the progenitor cells of a tissue. Approaches based on gene expression have led to conflicting views about the origin of the venous pole of the heart. Whereas the heart forms from 2 sources of progenitor cells, the first and second heart fields, genetic tracing has suggested a distinct origin for caval vein myocardium, from a proposed third heart field. Objective: To determine the cell lineage history of the myocardium at the venous pole of the heart. Methods and Results: We used retrospective clonal analyses to investigate lineage segregation for myocardium at the venous pole of the mouse heart, independent of gene expression.
G ene expression patterns and genetic tracing experiments
provide important insight into regional differences within a tissue or organ and between the progenitor cell populations that contribute to such subregions. Definition of differences in the underlying regulatory circuits by mutant analysis further reinforces the distinction between contributing cell sources. However, approaches based on gene expression and function are not necessarily informative about lineage and can lead to confusing or conflicting conclusions in this cellular context. 1 The formation of the venous pole of the heart provides a striking example of this sort of dilemma. In the mature heart, caval veins drain oxygen-poor blood from the systemic circulation into the right atrium, while pulmonary veins drain oxygen-rich blood from the lungs into the left atrium, as illustrated for the mouse model ( Figure 1A) . These veins, like the heart itself, are sheathed in myocardial cells, which surround the endothelial tube of these blood vessels. The origin of this myocardium continues to excite debate. [2] [3] [4] The mouse heart is formed from 2 mesodermal cell populations, the first and second heart fields. 5, 6 The second heart field (SHF) is a major source of cells that are added into the primary heart tube which has a mainly left ventricular (LV) identity. 7 Thus, the arterial pole of the heart forms from the pharyngeal splanchnic mesoderm of the SHF, from its anterior domain characterized by the expression of Fgf10. 6 The posterior part of the SHF contributes to the myocardium of the atria. 8 As the venous pole of the heart tube develops, the sinus venosus forms posteriorly, with symmetrically protruding sinus horns from which the caval veins derive. Myocardium is only added to the pulmonary vein from about E12.5, potentially also by recruitment of mesenchymal cells from the posterior SHF. 9 Three types of myocardium are molecularly distinguishable at the venous pole of the heart, characterized by different expression of genes [10] [11] [12] or transgenes. 13, 14 Based on overlapping expression profiles, it has been proposed that atrial myocardium grows out along the endothelial surface of the vein 15, 16 or that the caval vein and pulmonary vein myocardium have a common origin. 12 Examples of different expression patterns, for myosin transgenes and for the Pitx2C transcription factor, which is expressed on the left side of the embryo, are illustrated in Figure 1B .
Cardiac progenitor cells in the SHF, which contribute to the atria and to the pulmonary vein, express the transcription factor Islet1, which has been regarded as a marker of the SHF, 17 as well as Nkx2-5 also expressed in the myocardium. 11 In contrast, caval vein myocardium is distinguished by the absence of Nkx2-5 and the presence of another transcription factor, Tbx18, also detectable in surrounding mesenchymal cells from about E8. 25 . These cells are mainly negative for Islet1. Mutant analysis shows that Tbx18 is essential for the formation of caval vein myocardium. 18, 19 In an elegant series of genetic tracing experiments, using the Rosa26 reporter line, Christoffels et al 11, 18, 19 conclude that pulmonary vein myocardium does not derive from atrial myocardium because it is not labeled with a Nppa-Cre ( Figure  1C ). They show that caval vein myocardium forms from cells that do not activate an Nkx2-5-IRES-Cre, which gives labeling in the atria and pulmonary vein ( Figure 1C ). 11, 18 Cells in the posterior heart field adjacent to the sinus venosus, which are Tbx18 positive, are also marked by a transgene expressed in a territory located laterally to the cardiac crescent at earlier stages. Dye labeling experiments at this early lateral location marked cells that express Tbx18 in the venous pole of the heart at later stages, after embryo culture. These series of experiments therefore led to the conclusion that caval vein myocardium has a distinct origin, potentially from a third heart field that is distinguished from the SHF by its transcriptional regulation. 18, 19 Lineage studies, using retrospective clonal analysis, have established that 2 myocardial cell lineages contribute to the formation of the heart. These segregate very early and their contributions, the first to the primitive left ventricle and the second to the outflow tract at the arterial pole, with overlapping contributions to the right ventricle and atria, are analogous to those of the first and second heart fields, respectively. 5, 20 The venous pole of the heart, which forms later, was not investigated in detail in this analysis. The question of a third heart field, potentially emanating from a third lineage, has not been addressed.
We now report cell lineage results, based on retrospective clonal analysis at a later stage, for atrial, pulmonary, and caval vein myocardium, which lead to the construction of a lineage tree for the venous pole of the heart. This is consistent with a common contribution from the second myocardial cell lineage (SHF), which segregates into left and right components, contributing to the dorsal left atrium, pulmonary vein, and left superior caval vein or to the dorsal right atrium and right superior caval vein, respectively, with no indication of an independent sublineage for caval vein myocardium. Unexpectedly, the left lineage also contributes to the arterial pole, indicating that the posterior domain of the SHF also contributes to the most anterior part of the heart. We also demonstrate that gene expression and function are secondary features of these cardiac cell lineages.
Methods

Mice
Animal care was in accordance with national and institutional guidelines. The α c -actin nlaacZ1.1/nlaacZ1.1 line was used in conjunction with an αMHC-α c -actin transgene so that cardiac actin was present in the heart and homozygote α c -actin nlaacZ/nlaacZ mice were viable and could be mated. 20 We used a mouse line in which an inducible Cre-ERT2 sequence had been targeted to the Rosa26 locus (R26CreERT2 from Lars Grotewold and Austin Smith). The ROSA26R-nlacZ (R26R-nlacZ) line, in which an nlacZ sequence is conditionally expressed on recombination by Cre, was used as a reporter line (J.-F. Nicolas, E. Tzouanacou, and V. Wilson, unpublished). In these mice (R26CreERT2 or R26R-nlacZ), both alleles of Rosa26 are mutated, without any detectable phenotype. 21 The T4 mouse line expresses an nlacZ reporter under the regulation of 5′ sequences of the α-cardiacactin gene that lead to expression throughout the myocardium. 22 These mouse lines are all on a mixed genetic background (mainly C57B6/DBA2/129/SJL). Embryonic day (E) 0.5 was counted from the appearance of the vaginal plug.
Detailed Methods are provided in the Online Data Supplement.
Results
Clonal Analyses at E14.5
The retrospective clonal analysis used here avoids preconceived ideas on lineage relationships and relies on the random intragenic recombination of a nonfunctional nlaacZ sequence into a functional nlacZ, which in this case is targeted to the α-cardiac actin (α c -actin) gene expressed throughout the myocardium (Online Figure I) . The recombination event itself is totally independent of gene expression. To follow pulmonary vein myocardium that forms from E12.5, 9, 18 the analysis was carried out at E14.5 when the structure of the venous pole is as shown in Figure 1A . Using the α c -actin nlaacZ1.1/+ line, 23 we found 223 of 2028 (11.04%) hearts with informative labeling in the venous pole (see Methods and Online Table I ). The statistical comparison, based on observation of many embryos, between the observed frequency of double labeling (labeling at 2 distinct regions of the heart) and the expected frequency of more than one recombination event, establishes whether labeled cells descend from a single recombined progenitor and are therefore clonally related (see Methods). We complemented this analysis with a retrospective approach, which permits more precise control of the temporal parameter. In this approach, an inducible Cre recombinase from a Rosa26CreERT2 allele is used to target a conditional Rosa26R-nlacZ reporter. This reporter is not confined to myocardium but is widely expressed in the embryo. At low doses of 4-hydroxytamoxifen, activation of the Cre recombinase can be reduced to trigger a rare recombination event of the Rosa26R-nlacZ allele, resulting in nlacZ reporter expression. A total of 631 embryos were produced by tail vein injections of a low dose of 4-hydroxytamoxifen at E6.5, which gave only 9.8% of labeling at the venous pole (atria and veins), thus permitting clonal analysis (with a probability of a double recombination event of 1×10 −3 ; see Methods). No labeled cells were detected 6 hours after injection, and the first labeled cells were observed 12 to 18 hours after injection (data not shown), suggesting that the clone was born between E6.75 and E7.25. We made use of this approach as a temporal indicator, in conjunction with the more extensive α c -actin nlaacZ1.1/+ clonal analysis.
Non-standard Abbreviations and Acronyms
Atrial and Venous Myocardium Are Clonally Related
We first examined whether atrial and venous myocardium are clonally related. Because atrial myocardium may be regionalized, we have distinguished the dorsal and ventral parts of the atria. We obtained 9 α c -actin nlaacZ1.1/+ hearts with double labeling in the dorsal left atrium (dLA) and in the left superior caval vein (LSCV) (Online Figure II ). An example of such a clone is shown in Figure 2A . In this and other 3D reconstructions of the heart, high-resolution episcopic microscopy (HREM) permits visualization of β-galactosidase-positive cells in the vessel walls at the venous pole, where localization cannot be precisely described by standard whole-mount techniques. We have also observed 8 α c -actin nlaacZ1.1/+ hearts with double labeling in both the dLA and pulmonary vein (PV) ( Figure 2B and Online Figure II) . Labeling in the right atrium (RA) was accompanied by labeling in the right superior caval vein (RSCV) (n=13) ( Figure 2C and Online Figure II) . To assess whether a clonal relationship exists between atrial and venous myocardium, we compared the observed frequency of labeling in the 2 different regions with the expected frequency of double recombination events. This frequency was estimated on the basis of the law of independent probabilities: this is equal to the product of the frequency of labeling in each region. Double labeling events between the veins (LSCV, RSCV, or PV) and a region of the atrium (dorsal-LA, ventral-LA, dorsal-RA, or ventral-RA) were analyzed one by one ( Figure 2D and the Table) . A high ratio (>1) between the observed and expected frequencies of double labeling is indicative of a clonal relationship. If we consider first the LSCV, the observed frequency of double labeling in this vein and in the dorsal part of the left atrium (dLA) is 10-fold higher than the expected frequency ( Figure  2D ). Statistical analysis with the Fisher exact test confirms that such labeling has a very low probability of arising from independent recombination events (P=2×10 −6 ) (Table) . We also conclude that double labeling in the PV and LA is the product of a unique recombination event, because the observed frequencies were significantly higher than the expected frequencies ( Figure  2D ) (dLA and PV: P=4×10 −10 ; vLA and PV: P=2×10 −3 ) (Table) .
If we now consider the RSCV, the observed frequency of double labeling with the RA is significantly higher than the expected frequency, suggesting that this reflects a unique recombination event. The statistical analysis supports the conclusion that β-galactosidase-positive cells in the RSCV and in the RA arise from a common progenitor, with a more pronounced clonal relationship with the dorsal part of the RA (dRA: P=7×10 −15 ) than with the ventral part (vRA: P=7×10 −6 ).
Induction of clones at E6.5 also produced double labeling in the LSCV and LA, LSCV and PV, and RSCV and RA ( Figure 2E and 2F ), suggesting that the segregation between venous and atrial myocardial lineages arises after E6.75-E7. 25 . We also observed nonmyocardial β-galactosidase labeling (TnI negative; Figure 2E and 2F), indicating that progenitors giving rise to LSCV, LA and LSCV or RSCV and RA also contribute to other cardiac cell fates. In addition, with the exception of 1 heart, which may reflect independent recombination events, the induced labeling was found in either the left or right side of the venous pole suggesting that the segregation between the left and right lineages arises before E6.75-E7.25.
PV and LSCV Myocardium Are Clonally Related
We then examined whether caval and PV myocardium are clonally related. Whereas no hearts had double labeling in the RSCV and PV myocardium, we have observed 9 α cactin nlaacZ1.1/+ hearts with double labeling in LSCV and PV myocardium ( Figure 3A and 3B and Online Figure II ). The comparison between the observed and expected frequencies of double labeling shows that the PV and LSCV arise from common progenitors, and this was confirmed by statistical analysis. The probability that double labeling arises from independent recombination events is very low (P=3×10 −11 ; Table) . However, the clonal relationship between the PV and LSCV is more pronounced with the distal part of the LSCV (P=3×10 −11 ) than with the proximal part of the vein (P=8×10 −6 ) ( Figure 3C ).
A clone with β-galactosidase-positive cells in the LA, LSCV, and PV myocardium produced by injection of 4-hydroxytamoxifen at E6.5 is shown in Figure 3D , suggesting that the segregation between these different lineages arises after E6.75-E7.25.
Arterial and Venous Myocardium Are Clonally Related
Arterial pole myocardium is exclusively derived from the second myocardial cell lineage, whereas both first and second lineages contribute to atrial myocardium. 5, 20 To distinguish first versus second lineage contributions, we therefore examined whether the veins share common progenitors with the We used the nonparametric Fisher exact test to assess whether double labeling results from 2 independent events. Each region was tested for independence with another region of the heart. P values are indicated in the table.
*P value was lower than 5×10 -2 , leading to the conclusion that the labeling is likely to derive from a single recombination event and that the 2 regions are clonally related. The large range of significant P values reflects different cellular components with distinct clonal relationships within a compartment, as shown for the pulmonary trunk at the arterial pole. October 26, 2012 myocardium surrounding the great arteries (pulmonary trunk and aorta). We found 9 α c -actin nlaacZ1.1/+ hearts with colabeling in the myocardium surrounding the veins and at the base of the great arteries ( Figure 4A and Online Figure II) . The comparison between the observed and expected frequencies of double labeling demonstrates that arterial pole myocardium is clonally related to the dLA (P=1×10 −2 ) and both the LSCV (P=8×10 −5 ) and PV (5×10 −4 ) myocardium ( Figure 4B and the  Table) . This unexpected finding indicates that arterial pole myocardium shares common progenitors with the left components of the venous pole. This clonal relationship is more pronounced with the pulmonary trunk myocardium. Eight α cactin nlaacZ1.1/+ hearts had labeling in the left venous pole and in the myocardium surrounding the pulmonary trunk, including 2 hearts with colabeling in the myocardium surrounding the aorta, whereas no clones showed colabeling in the venous pole and in the myocardium surrounding only the aorta.
Right ventricular myocardium is also largely derived from the anterior SHF. 6, 7 Comparison between the observed and expected frequencies of double labeling did not show any significant relationship between the LSCV, RSCV, or PV with the RV ( Figure 4B and the Table) . However, a significant relationship was observed between the vRA and the RV (P=2×10 −2 ; Figure 4B and the Table) . As expected, a significant relationship was observed between the RV and arterial pole (P=2×10 −2 ; Table) . In contrast, no clonal relationships were observed with left ventricular myocardium that derives from the first lineage 20 (Table) .
Aspects of Cell Behavior in the Myocardium Surrounding the Veins
This retrospective clonal analysis also allowed us to investigate aspects of cell behavior in the myocardium surrounding the veins. We first noticed that α c -actin nlaacZ1.1/+ clones were organized in oriented lines of β-galactosidase-positive cells in the LSCV, as illustrated in Figure 5A , notably in parallel to the vein in the proximal part ( Figure 5B ). In contrast, in the distal part of the LSCV, the clones were organized around the circumference of the vein ( Figure 5C ). These results therefore show that the LSCV myocardium follows 2 modes of oriented growth, whereas the RSCV and PV myocardium only shows circumferential growth (examples are shown in Online Movies I and II).
In the PV myocardium, we obtained many large clones. This is consistent with a high number of proliferative cells in this myocardium 11 (Online Figure III) . Notably, we observed that the frequency of clones in the PV increased with their size ( Figure 5D ). This is typical of a stem cell mode of growth (Online Figure IV) . 24 In contrast, the frequency of clones decreased with the size of the clone for atrial and caval vein myocardium ( Figure 5D ), typical of a proliferative mode of growth (Online Figure IV) . 24 We then investigated the localization of the clones along the proximo-distal axis of the veins. Although in the left superior caval vein, clones are located randomly along the vein with no preferential regionalization ( Figure 5F) , almost all the clones in the pulmonary vein extend to the more promixal end, corresponding to the base of the vein ( Figure  5E ). This is consistent with a stem cell-like mode of growth with a self-renewing pool of cells located at the base of the vein. In the context of this different growth mode, small clones are generated over a longer time period. We checked all the PV clones in our statistical analysis. This gave similar results on clonal relationships to those shown in the Table.
Discussion
The retrospective clonal analysis described in the present study for the venous pole of the heart results in the lineage tree shown in Figure 6A . Despite molecular differences, , or PV myocardium. The ratio is statistically higher than 1 between the AP and the dLA (probability value=0.01 or 1×10 −2 ), between the AP and the LSCV (probability value=8×10 −5 ), between the AP and the PV (probability value=5×10 −4 ), and between the RV and the vRA (probability value=2×10 −2 ) . Numbers at the bottom right refer to the specific embryos. myocardium of the pulmonary or caval veins shares common progenitors with atrial myocardium, notably with the dorsal part of the atria. Furthermore, left superior caval vein and PV myocardium are clonally related. This is in contrast to the conclusions suggested by genetic tracing experiments ( Figure 6B ).
Early segregation takes place between left and right components of the venous pole, separating myocardial progenitors of the left atrium, the left superior caval vein, and the pulmonary vein from those of the right atrium and right superior caval vein. This segregation probably occurs at the time of gastrulation, when mesoderm separates on either side of the primitive streak. 25, 26 As expected, Pitx2C expression, which is a read-out of later left/right signaling, marks these structures at the left side of the venous pole ( Figure 1B) . 14, 27 Pitx2C is also expressed on the left side of the posterior second heart field; explant experiments monitoring the left/right myocardial potential of this domain, together with dye tracking of cells, showed that left atrial myocardium derives from the left side of the field. 8 Unexpectedly, myocardium at the venous pole shows clonality with the myocardium of the pulmonary trunk at the arterial pole of the heart. This clonal relationship is seen with the left side of the venous pole. Previous clonal analysis had shown the contribution of the left pharyngeal mesoderm to a subset of skeletal muscles on the left side of the head and to pulmonary trunk myocardium, 26 consistent with left segregation of progenitors.
Outflow tract myocardium, which subsequently locates to the base of the aorta and pulmonary trunk, derives exclusively from the second myocardial cell lineage. 20 In this previous analysis, the atria were shown to have contributions from both first and second lineages; the early end point (E8.5) precluded any conclusions about the pulmonary or caval veins. Since we now show that pulmonary trunk myocardium is clonally related to venous pole myocardium and that there is no clonal relationship with left ventricular myocardium that derives exclusively from the first lineage, 20 we conclude that pulmonary and caval vein myocardium derive from the second lineage. This would also suggest that the dorsal part of the atria may be preferentially of this origin. Since the second lineage contribution correlates with that of the second heart field, 5 this is consistent with the late recruitment of mesodermal cells to both caval and pulmonary vein myocardium, 28 from the posterior second heart field.
Outflow tract myocardium is formed by progenitor cells, which are recruited from the anterior part of the second heart field, including the mesodermal core of the pharyngeal arches ( Figure 6C, left) , as evidenced by dye labeling and genetic tracing. 6 Many genes, such as Fgf8/10, are only expressed in this part of the heart field, and their mutant phenotypes are confined to the arterial pole of the heart. 29 In this context, it is very surprising that pulmonary trunk myocardium shares common progenitors with venous myocardium. This might imply that the myocardial lineages of the pulmonary trunk and caval and pulmonary veins had segregated before establishment of the heart fields. However, this is unlikely, given the lineage tree ( Figure 6A ) and the fact that there is no clonal relationship with left ventricular myocardium derived from the first heart field. Furthermore, right ventricular myocardium, which is also mainly derived from the anterior SHF, shows no clonal relationship with venous pole myocardium, with the exception of the ventral right atrium. However, it is the dorsal part of the atrium that has strong clonal relationships with the caval and pulmonary veins. Alternatively, some outflow tract progenitors may move from the posterior to the anterior region of the heart field, where they then express typical anterior markers. Dye injections in the posterior SHF also showed a contribution to the proximal and distal outflow tract. 30 Moreover, a recent report on HoxB1-expressing cells is in favor of this second alternative. HoxB1 is expressed in the posterior domain of the second heart field. In HoxB1-Cre; Rosa26R embryos, reporter labeling is observed in the atria as expected for the stage examined (E15.5) but also in pulmonary trunk myocardium. 31 This would suggest that posteriorly located HoxB1-positive cells have moved anteriorly to contribute to arterial pole myocardium and specifically to pulmonary trunk myocardium, as also observed in the clonal analysis. As a word of caution, it is possible that in both cases, a contribution to the base of the aorta may have been missed because this myocardial sleeve is much less prominent than that of the pulmonary trunk. It is also possible, since the SHF gives rise to smooth muscle and the aorta has a major smooth muscle sleeve, that part of this aortic smooth muscle has a clonal relationship with the venous pole, not revealed in the α c -actin nlaacZ1.1/+ analysis.
Clonal analysis also gives information about cell behavior. Thus, we had previously observed oriented clonal cell growth, which we had proposed underlies cardiac morphogenesis. 32 In the case of the arterial pole of the heart, clones in the embryonic outflow tract were oriented in parallel with this tubular structure, except in the region proximal to the ventricle where they assumed a circumferential orientation. Subsequently, after septation and formation of the pulmonary trunk and aorta, myocardial clones were oriented around the 11, 18, 19 ). B, Tree deduced from genetic tracing experiments, based on the expression of Nppa (red), Nkx2-5 (pink), and Tbx18 (orange). 11, 18, 19 C, Model of the sublineages inside the second heart field. The anterior second heart field (aSHF), marked by Fgf10 expression, 6 is represented in dark green; the posterior second heart field (pSHF), marked by Hoxb1 expression, 31 is represented in light green. The left domain of the second heart field is marked by Pitx2c expression 27 (pale gray stripes). On the right, a lineage tree of the second heart field derivatives is shown. In the box outlined in gray, the lineage tree deduced for the myocardium at the arterial pole of the heart together with the contribution to skeletal muscles of the head, derived from the first and second branchial arches, is presented 26 (corresponding to the anterior sublineage). In bold, the pulmonary trunk is found in this distinct branch but also in the posterior sublineage described here. BA indicates branchial arch; FHF, first heart field; RV, right ventricle; RSCV, right superior caval vein; RA, right atrium; PV, pulmonary vein; LSCV, left superior caval vein; LA, left atrium. base of these arteries. 33 In the case of the venous pole, we observed that clones are oriented parallel to the wall of the left superior caval vein, except in the distal region, furthest from the atrial chamber, where they are circumferential. Pulmonary vein and right superior caval vein myocardium showed circumferential growth. This difference is consistent with the major elongation of the LSCV, which extends across the mature heart. Strikingly, the clonal analysis reveals that PV myocardium has undergone a stem cell-like mode of proliferation, unlike other myocardial domains at the venous or at the arterial pole. This may reflect an early role of the pulmonary pit, which is the point of connection between the pulmonary vein and the heart, 34, 35 as a proliferative center for PV outgrowth, in addition to recruitment of proliferating cells from the second heart field.
In conclusion, we have established a lineage tree for the venous pole of the heart. The clonal relationships revealed by our analysis do not always correlate with differences between progenitor populations shown by genetic tracing. This underlines the distinction between gene expression and gene regulatory networks compared with lineage per se, in these complementary aspects of the history of a cell. Tbx18positive, Nkx2-5-negative cells contribute to caval vein myocardium, but this domain of gene expression, initially positioned laterally to the cardiac crescent, does not reflect an earlier lineage segregation from atrial or pulmonary vein progenitors. However, the onset of gene expression in subpopulations of progenitor cells provides important insight into the segregation of sublineages. Tbx18 expression and the absence of Nkx2-5 mark the right and left caval vein branches of the lineage tree. Because this expression is observed in progenitor cells from E8.25, it indicates that segregation takes place before E8.25 ( Figure 6C ). For clonal analysis, the tamoxifeninducible approach also gives temporal information. In the experiments described here, the left/right segregation of lineages must take place before tamoxifen activation of the Cre recombinase in the time window of E6.75-E7.25, in keeping with the establishment of left/right territories at the time of gastrulation. The unexpected lineage relationship, revealed by our clonal analysis, between the venous myocardium and the pulmonary trunk at the arterial pole of the heart, which is supported by Hoxb1 genetic tracing, leads us to propose a lineage tree that underlines their common origin ( Figure 6C , right). Hoxb1 expression is initiated at E7.25, indicating that the segregation of anterior and posterior sublineages precedes this time point.
We had previously shown that arterial pole myocardium and skeletal muscles of the head share common progenitors, such that a first sublineage contributes to the right ventricle and to masticatory muscles and a second sublineage contributes to myocardium at the base of the aorta and pulmonary trunk and to facial expression muscles. 26 The question therefore arises of clonality between head muscles and venous pole myocardium. We did not find any evidence of this and therefore conclude that pulmonary trunk myocardium derives from 2 distinct sublineages. These sublineages may correspond to the anterior and posterior second heart field that have been described previously ( Figure 6C ). [6] [7] [8] 12 Congenital heart defects at the arterial pole are particularly frequent (about 30% of the affected 1% of neonates) in the human population and in some cases are linked to a venous pole defect that was frequently not detected and therefore not corrected in the past. 36 This was ascribed to a contribution of the second myocardial cell lineage also to the venous pole. Our current study clarifies this connection and underlines the importance of characterizing the arterial pole defects that arise from a failure in the pulmonary trunk/venous pole sublineage, which should also be diagnostic of potential venous pole defects.
What Is Known?
• The mouse heart is formed from 2 myocardial cell lineages, where the second lineage, which correlates with the second heart field, contributes all the myocardium of the outflow region at the arterial pole and also contributes to the right ventricle and both atria. • The relationship between the myocardium that surrounds the caval and pulmonary veins has remained controversial and it has been proposed that caval vein myocardium has a distinct origin from the rest of the venous pole. • Caval vein, pulmonary vein, and atrial myocardium have distinct gene expression patterns and derive from progenitor cells that show differences in gene expression, leading to the suggestion of a distinct origin for caval vein myocardium.
What New Information Does This Article Contribute?
• Cells that give rise to the myocardium at the left and right sides of the venous pole segregate early during development. The left-side pulmonary and left superior caval vein myocardium share common progenitors with dorsal left atrial myocardium. On the right side, right superior caval vein and dorsal right atrial myocardium share common progenitors. • There is no indication that caval vein myocardium derives from a distinct lineage.
• Arterial and venous myocardium also share common progenitors, demonstrating the relation with the second myocardial cell lineage, which is the only source of arterial pole myocardium.
The second myocardial lineage corresponds to a source of cells that contributes to arterial pole, right ventricular, and atrial myocardium. The great veins are also surrounded by myocardium, but the origin and relationship to the first or second myocardial lineage has remained controversial. We used clonal analyses to investigate the origin of the venous pole of the mouse heart. We show in the current study that there is an early segregation between the left and right components of the venous pole and that the dorsal part of the right or left atrial myocardium is clonally related to the right or left superior caval vein myocardium, respectively. Pulmonary vein myocardium belongs to the left sublineage because it is clonally related to left atrial and left superior caval vein myocardium. We also found that arterial pole myocardium, at the base of the pulmonary trunk, belongs to this lineage, demonstrating the relation of venous pole myocardium to the second myocardial lineage. The current study clarifies the origin of the venous myocardium and illustrates the difference between genetic tracing experiments and lineage analysis. These findings are relevant to congenital heart defects that affect not only the arterial pole but also the venous pole of the heart.
Novelty and Significance
